Sign Up to like & get
recommendations!
0
Published in 2018 at "Cancer cell"
DOI: 10.1016/j.ccell.2018.08.012
Abstract: One of the biggest challenges in treating acute myeloid leukemia (AML) is relapse of aggressive disease after treatment. In this issue of Cancer Cell, Boyd et al. characterize a molecularly distinct population of chemotherapy-induced transient leukemic regenerating…
read more here.
Keywords:
targeting residual;
residual leukemia;
leukemia cells;
cells chemotherapy ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2017 at "Oncotarget"
DOI: 10.18632/oncotarget.13772
Abstract: Advanced breast cancer (eg. stage IV) is resistant to chemotherapy. In this work, we identified potentially druggable targets that are critically involved in chemoresistance. We showed that eIF4E is highly phosphorylated at serine 209 in…
read more here.
Keywords:
breast;
catenin;
breast cancer;
cancer cells ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2019 at "Yonsei Medical Journal"
DOI: 10.3349/ymj.2019.60.2.182
Abstract: Purpose This study aimed to investigate the effects of PIK3CA on the sensitivity of acute B lymphocytic leukemia cells (Nalm-6 cells) to chemotherapy drugs. Materials and Methods Children's normal B lymphocytes and Nalm-6 cells were…
read more here.
Keywords:
chemotherapy drugs;
leukemia cells;
group;
sensitivity ... See more keywords
Sign Up to like & get
recommendations!
2
Published in 2022 at "Journal of Cancer"
DOI: 10.7150/jca.65871
Abstract: Chemotherapy is an important treatment for gastric cancer (GC), but the primary and secondary drug resistance of tumours to chemotherapy seriously affects its curative effect. In recent years, the relationship between long noncoding RNAs (lncRNAs)…
read more here.
Keywords:
crnde;
lncrna crnde;
cells chemotherapy;
gastric cancer ... See more keywords